| Net income | 85.9M |
| Loss from discontinued operations, net of tax | |
| Gain on sale of operations, net | |
| Depreciation and amortization expense | |
| Amortization of discount on notes and deferred financing costs | |
| Bad debt expense, net of recoveries | |
| Adjustment to contingent earnout liability | |
| Deferred income taxes | |
| Employee stock awards | |
| Excess tax benefits from share based payment arrangements | |
| Restricted cash | |
| Accounts receivable, net | |
| Other assets | |
| Accounts payable | |
| Income taxes payable/refundable | |
| Accrued personnel costs and other liabilities | |
| Net cash provided by continuing operations | |
| Operating cash flows used in discontinued operations | |
| Net cash provided by operating activities | |
| Business acquisitions and contingent consideration, net of cash acquired | |
| Purchases of client fund investments | |
| Proceeds from the sales and maturities of client fund investments | |
| Proceeds from sales of divested and discontinued operations | |
| Net (increase) decrease in funds held for clients | |
| Additions to property and equipment, net | |
| Other | |
| Net cash used in investing activities | |
| Proceeds from bank debt | |
| Payment of bank debt | |
| Repurchase of convertible notes | |
| Payment for acquisition of treasury stock | |
| Net increase (decrease) in client funds obligations | |
| Proceeds from exercise of stock options | |
| Payment of contingent consideration of acquisitions | |
| Excess tax benefit from exercise of stock awards | |
| Debt issuance costs | |
| Other | |
| Net cash provided by (used in) financing activities | |
| Net decrease in cash and cash equivalents | |
| Cash and cash equivalents at beginning of year | |
| Cash and cash equivalents at end of period | |